Results 131 to 140 of about 205 (151)
Some of the next articles are maybe not open access.
[ANTIOXIDANT AND CYTOPROTECTOR PROPERTIES OF GENISTEIN - ISOFLAVONE WITH ESTROGENIC ACTIVITY.]
Eksperimental'naia i klinicheskaia farmakologiia, 2018Phytoestrogen genistein can exhibit cytoprotective and antioxidant properties, providing chemopreventive action, and produce cytotoxic effects on some tu- mors. In this work, the cytotoxic, cytoprotective, and antioxidant properties of genistein have been studied on model tumor cells (human cervical cancer HeLa cells) and normal cells (rat dermal ...
T A, Fedotcheva +3 more
openaire +1 more source
Melatonin as a Chronobiotic and Cytoprotector in Non-communicable Diseases: More than an Antioxidant
A circadian disruption, manifested by disturbed sleep and low-grade inflammation, is commonly seen in noncommunicable diseases (NCDs). Cardiovascular, respiratory and renal disorders, diabetes and the metabolic syndrome, cancer, and neurodegenerative diseases are among the most common NCDs prevalent in today's 24-h/7 days Society. The decline in plasmaDaniel P. Cardinali +2 more
openaire +2 more sources
Possibilities of using cytoprotectors in complex therapy of chronic coronary heart disease
Russian Journal of Cardiology and Cardiovascular SurgeryThe chronic form of coronary heart disease (CHD) is one of the most common types of cardiovascular pathology in the Russian Federation. The main causes of myocardial ischemia are a decrease in coronary reserve, as well as a decrease in coronary blood flow due to atherosclerotic stenosis.
V.P. Mikhin +2 more
openaire +1 more source
Melatonin as a Chronobiotic and Cytoprotector in Healthy Aging
2023Daniel P. Cardinali +2 more
openaire +1 more source
Klinicheskaia meditsina, 2011
The study included 1418 patients with FC I-IV stable angina of effort (42.4% men and 57.6% women, mean age 74.6 +/- 1.2 years). The possibility to supplement standard therapy with myocardial cytoprotectors (trimetasidin, mexidol, qudesan) was estimated in 4 groups of patients from the severity of pain syndrome, chronic cardiac insufficiency, and heart ...
V B, Simonenko +2 more
openaire +1 more source
The study included 1418 patients with FC I-IV stable angina of effort (42.4% men and 57.6% women, mean age 74.6 +/- 1.2 years). The possibility to supplement standard therapy with myocardial cytoprotectors (trimetasidin, mexidol, qudesan) was estimated in 4 groups of patients from the severity of pain syndrome, chronic cardiac insufficiency, and heart ...
V B, Simonenko +2 more
openaire +1 more source
ASTHENIC POST-COVID-19 SYNDROME: CLINICAL EFFICACY OF CYTOPROTECTORS
Vestnik SurGU. MeditsinaThe study aims to assess the mechanism and efficacy of cytoprotectors as a supplementary therapy for asthenia based on a literature review. The study discusses the cardioprotective effect of exogenous phosphocreatine and meldonium efficacy, their possible role following the COVID-19 infection, especially in concomitant cardiac pathology, post-COVID-19 ...
openaire +1 more source
Klinicheskaia meditsina, 2015
The authors report comparative analysis of the efficacy of cytoprotectors and basal therapy used to treat widespread forms of psoriasis. Combination of both modalities including remaxol and ademetionine increases the effectiveness of the treatment by 23% as appears from the decrease of PASI of 89.6% patients from 23.6 +/- 2.2 to 5.7 +/- 2.2 scores.
R A, Grashin +2 more
openaire +1 more source
The authors report comparative analysis of the efficacy of cytoprotectors and basal therapy used to treat widespread forms of psoriasis. Combination of both modalities including remaxol and ademetionine increases the effectiveness of the treatment by 23% as appears from the decrease of PASI of 89.6% patients from 23.6 +/- 2.2 to 5.7 +/- 2.2 scores.
R A, Grashin +2 more
openaire +1 more source
The role of cytoprotectors in the treatment of patients with chronic forms of coronary heart disease
Therapy, 2021Gromnatsky N.I. Gromnatsky +2 more
openaire +1 more source
Circulating HSP70 as an Endogenous Cytoprotector?
2009Alan Graham Pockley, Gabriele Multhoff
openaire +1 more source
Eksperimental'naia i klinicheskaia farmakologiia, 2010
Hepatoprotective effect of metabolism correctors has been studied on the model of experimental viral and toxic damage of the liver. Reamberin-based substrate compositions (cytoflavin and remaxol) exhibit antihypoxic effect, antioxidant activity, and cytoprotective action on the background of metabolic effect.
D S, Sukhanov +4 more
openaire +1 more source
Hepatoprotective effect of metabolism correctors has been studied on the model of experimental viral and toxic damage of the liver. Reamberin-based substrate compositions (cytoflavin and remaxol) exhibit antihypoxic effect, antioxidant activity, and cytoprotective action on the background of metabolic effect.
D S, Sukhanov +4 more
openaire +1 more source